LEADER 01701 am 22003373u 450 001 9910765842003321 005 20200115 010 $a9783631383148 024 7 $a10.3726/b14097 035 $a(CKB)4100000007523246 035 $a(OAPEN)1003315 035 $a(EXLCZ)994100000007523246 100 $a20200115d|||| uy 101 0 $ager 135 $auuuuu---auuuu 200 10$aQualitaetsorientierte Verguetungssysteme in der ambulanten und stationaeren Behandlung 210 $aBern$cPeter Lang International Academic Publishers$d2018 215 $a1 online resource (280) 311 $a3-631-38314-2 330 $aDer Sammelband enthält die erweiterten Referate eines interdisziplinären Workshops über qualitätsorientierte Vergütungssysteme in der ambulanten und stationären Behandlung. Diskutiert werden die vier Themenkreise Priorisierung von Gesundheitszielen, Vergütungssysteme im ambulanten Bereich, Vergütungssysteme im stationären Bereich sowie integrierte Versorgungsformen. Der Teilnehmerkreis setzt sich aus Vertretern der Ärzteschaft, Krankenkassen und -versicherungen, der pharmazeutischen Industrie, der Wissenschaft, der ministerialen Bürokratie und der Politik zusammen. 517 $aAllokation im marktwirtschaftlichen System vol. 44 606 $aHealth economics$2bicssc 606 $aMedical sociology$2bicssc 615 7$aHealth economics 615 7$aMedical sociology 701 $aAlbring$b Manfred$f1943-$01278166 701 $aWille$b Eberhard$f1942-$01449570 906 $aBOOK 912 $a9910765842003321 996 $aQualitaetsorientierte Verguetungssysteme in der ambulanten und stationaeren Behandlung$93648006 997 $aUNINA LEADER 03774nam 2200685Ia 450 001 9910782987903321 005 20230721005356.0 010 $a1-4443-6059-0 010 $a1-282-00763-7 010 $a9786612007637 010 $a1-4443-0357-0 010 $a1-4443-0358-9 035 $a(CKB)1000000000722814 035 $a(EBL)416492 035 $a(OCoLC)476248454 035 $a(SSID)ssj0000231079 035 $a(PQKBManifestationID)11187388 035 $a(PQKBTitleCode)TC0000231079 035 $a(PQKBWorkID)10216957 035 $a(PQKB)10180872 035 $a(MiAaPQ)EBC416492 035 $a(Au-PeEL)EBL416492 035 $a(CaPaEBR)ebr10300898 035 $a(CaONFJC)MIL200763 035 $a(EXLCZ)991000000000722814 100 $a20080529d2009 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aQuality in laboratory hemostasis and thrombosis$b[electronic resource] /$fSteve Kitchen, John D. Olson, F. Eric Preston 210 $aChichester, West Sussex ;$aHoboken, NJ $cWiley-Blackwell$d2009 215 $a1 online resource (227 p.) 300 $aDescription based upon print version of record. 311 $a1-4051-6803-X 320 $aIncludes bibliographical references and index. 327 $aContents; Contributors; Foreword; Preface; 1: General quality planning in the hemostasis laboratory; 2: Hemostasis test validation, performance and reference intervals; 3: International Standards in hemostasis; 4: Sample integrity and preanalytical variables; 5: Internal quality control in the hemostasis laboratory; 6: External quality assessment in hemostasis: its importance and significance; 7: Initial evaluation of hemostasis: reagent and method selection; 8: Point-of-care testing in hemostasis; 9: Assay of factor VIII and other clotting factors 327 $a10: Application of molecular genetics to the investigation of inherited bleeding disorders11: Standardization of D-dimer testing; 12: Diagnostic assessment of platelet function; 13: Laboratory evaluation of von Willebrand disease: phenotypic analysis; 14: Laboratory analysis of von Willebrand disease: molecular analysis; 15: Dilemmas in heritable thrombophilia testing; 16: Evaluation of antiphospholipid antibodies; 17: Monitoring heparin therapy; 18: Monitoring oral anticoagulant therapy; 19: Monitoring new anticoagulants; 20: Detecting and quantifying functional inhibitors in hemostasis 327 $aIndex 330 $a""Over the last decades, major progress has been made in quality assurance of hemostatic laboratory assays. This book will be an indispensable part of every hemostasis laboratory, where, given its hands-on nature, it will rarely sit to get dusty on the shelves.""-Frits R. Rosendaal, Leiden University Medical Center The hemostasis laboratory has a vital role in the diagnosis and management of patients with familial and acquired hemorrhagic and thrombotic disorders. Its role in the monitoring traditional anticoagulant therapy as well as therapy using new anticoagulants presents 606 $aBlood coagulation disorders$xDiagnosis 606 $aBlood$xAnalysis$vLaboratory manuals 606 $aHemostasis 606 $aThrombosis 615 0$aBlood coagulation disorders$xDiagnosis. 615 0$aBlood$xAnalysis 615 0$aHemostasis. 615 0$aThrombosis. 676 $a616.1/57075 700 $aKitchen$b Steve$cDr.$0860323 701 $aOlson$b John David$f1944-$0860324 701 $aPreston$b F. E$0860325 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910782987903321 996 $aQuality in laboratory hemostasis and thrombosis$91919643 997 $aUNINA